Literature DB >> 17097052

Inhibition of receptor internalization attenuates the TNFalpha-induced ROS generation in non-phagocytic cells.

Chang-Hoon Woo1, Tae-Hee Kim, Jung-A Choi, Ho-Cheol Ryu, Jung Eun Lee, Hye-Jin You, Yun-Soo Bae, Jae-Hong Kim.   

Abstract

Reactive oxygen species (ROS) are important regulatory molecules implicated in the signaling cascade triggered by tumor necrosis factor (TNF)alpha, although the events through which TNFalpha induces ROS generation are not well characterized. Here, we report that TNFalpha-induced ROS production was blocked by pretreatment with internalization inhibitor monodansyl cadaverine (MDC). Similarly, a transient expression of a GTP-binding and hydrolysis-defective dynamin mutant (dynamin(K44A)) that had been shown to be defective in internalization significantly attenuated the TNFalpha-induced intracellular ROS production. Importantly, the inhibition of receptor internalization suppressed TNFalpha signaling to mitogen-activated protein kinases (MAPKs) stimulation. Together, our results suggest that receptor internalization is somehow necessary for the TNFalpha-induced ROS generation and subsequent intracellular downstream signaling in non-phagocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17097052     DOI: 10.1016/j.bbrc.2006.10.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Redox modifier genes and pathways in amyotrophic lateral sclerosis.

Authors:  Barrie J Carter; Pervin Anklesaria; Stephanie Choi; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

2.  NADPH oxidase 2 inhibitor diphenyleneiodonium enhances ROS-independent bacterial phagocytosis in murine macrophages via activation of the calcium-mediated p38 MAPK signaling pathway.

Authors:  Yuanfeng Zhu; Shijun Fan; Ning Wang; Xiaoli Chen; Yongjun Yang; Yongling Lu; Qian Chen; Jiang Zheng; Xin Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  IGF-1 induces expression of zinc-finger protein 143 in colon cancer cells through phosphatidylinositide 3-kinase and reactive oxygen species.

Authors:  A Rome Paek; Seok Hyun Kim; Sun Shin Kim; Kyung Tae Kim; Hye Jin You
Journal:  Exp Mol Med       Date:  2010-10-31       Impact factor: 8.718

Review 4.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

Review 5.  TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.

Authors:  Lauren M Workman; Hasem Habelhah
Journal:  Cell Signal       Date:  2013-04-21       Impact factor: 4.315

6.  Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis.

Authors:  Yasunori Kageyama; Masaaki Takahashi; Tetsuyuki Nagafusa; Eiji Torikai; Akira Nagano
Journal:  Rheumatol Int       Date:  2007-07-28       Impact factor: 2.631

7.  Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells.

Authors:  Jin-Wook Lee; Jae-Hong Kim
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

8.  A differential role for endocytosis in receptor-mediated activation of Nox1.

Authors:  Francis J Miller; Xi Chu; Bojana Stanic; Xin Tian; Ram V Sharma; Robin L Davisson; Fred S Lamb
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

9.  Etanercept treatment reduces the serum levels of interleukin-15 and interferon-gamma inducible protein-10 in patients with rheumatoid arthritis.

Authors:  Tetsuya Ichikawa; Yasunori Kageyama; Hayato Kobayashi; Norihiko Kato; Kunio Tsujimura; Yukio Koide
Journal:  Rheumatol Int       Date:  2010-01-10       Impact factor: 2.631

10.  Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis.

Authors:  Yasunori Kageyama; Tetsuya Ichikawa; Tetsuyuki Nagafusa; Eiji Torikai; Masahiro Shimazu; Akira Nagano
Journal:  Rheumatol Int       Date:  2007-07-10       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.